GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N93022C00013GENECURE LLC

Overview

Award facts

Net obligations
$300K
$300,000of $300K potential value
Outlays (paid to date)
$300K
$300K paid of $300K obligated$300,000
Period of performance
Jul 1, 2022 to Aug 31, 2023
Ended
Modifications
1
Latest action May 17, 2023
Contract type
Definitive contract
PIID 75N93022C00013

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

THE GOAL OF THE PROPOSED PROJECT IS TO DEVELOP AN HIV VACCINE PLATFORM FOR DELIVERY OF HIV ENV IMMUNOGEN THAT PRESENTS ANTIGEN AS NATIVE CONFORMATION AND INDUCES BNABS.

Dates and value

Award date
Signed on Jun 27, 2022
Potential end of performance
Aug 30, 2023
Current value
$300,000Base and exercised options
Potential value (if all options are exercised)
$300,000

Obligations by fiscal year of action

  • FY2022: $300,000

Total across 1 fiscal year: $300,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 17, 2023. View on USAspending · Recipient on SAM.gov

Recipient

LocationNORCROSS, GA
UEILFPEB7MMJCG3
CAGE code47U94
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyGENECURE LLC

Business types and certifications

Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationLimited liability companyCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Norcross, Gwinnett County, Georgia 30071-1556
Congressional district (place of performance)
GA-04As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
3

Solicitation and notices

Solicitation ID
SBIRPHS2022-1(as reported)
Solicitation date
Jul 28, 2021

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 27, 2022Base obligation at award: $300,000
Latest action
May 17, 2023 — Other administrative actionModification P00001; administrative: no change in scope or value
Actions by type
  • Base award1
  • Other administrative action1
2 actions recorded, Jun 27, 2022 to May 17, 2023; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Research program (SBIR/STTR)
Small business innovation research program phase i actionSR1
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
2

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2022/2022-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression